Thus, this indicates that RasGRF1 downregulation may contribute to the reduction in structural plasticity and subsequent cognitive impairment after CCH, and RasGRF1 upregulation could improve them. This evidence concerns the gene RASGRF1 and columnar cell hyperplasia of the breast.